Merus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.

CEO

Sven Ante Lundberg

CEOSven Ante Lundberg

Employees

260

Employees260

Headquarters

Utrecht, Utrecht

HeadquartersUtrecht, Utrecht

Founded

2003

Founded2003

Employees

260

Employees260

MRUS Key Statistics

Market cap

7.19B

Market cap7.19B

Price-Earnings ratio

-17.13

Price-Earnings ratio-17.13

Dividend yield

—

Dividend yield—

Average volume

8.31M

Average volume8.31M

High today

$94.95

High today$94.95

Low today

$94.56

Low today$94.56

Open price

$94.77

Open price$94.77

Volume

1.27M

Volume1.27M

52 Week high

$95.02

52 Week high$95.02

52 Week low

$33.19

52 Week low$33.19

MRUS News

TipRanks 4h

Oppenheimer positive on CytomX after Merus colon cancer data

Oppenheimer says Merus’ (MRUS) colon cancer data update reinforces its “enthusiasm” for CytomX Therapeutics’ (CTMX) dose expansion data. The Merus Phase 2 resul...

TipRanks 7h

Hold Rating on Merus’s Petosemtamab: Awaiting More Data for Colorectal Cancer Efficacy

Needham analyst Ami Fadia has maintained their neutral stance on MRUS stock, giving a Hold rating yesterday. Elevate Your Investing Strategy: Take advantage of...

TipRanks 9h

Merus announces initial interim data from phase 2 trial of petosemtamab

Merus (MRUS) N.V. announced initial interim clinical data as of an April 28, 2025 data cutoff from the ongoing phase 2 trial of the bispecific antibody petosemt...

Analyst ratings

88%

of 17 ratings

Buy

11.8%

Hold

88.2%

Sell

More MRUS News

Simply Wall St 24h

Assessing Merus Valuation After Its Recent Share Price Surge

Merus (MRUS) has posted impressive gains lately, catching the attention of investors as its stock climbed more than 35% over the past month and over 70% in the...

People also own

Based on the portfolios of people who own MRUS. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…